PCSK9功能丧失变体的结构动态:对LDL胆固醇调节和心血管风险的影响
Mohammed Tarique1, Ayyub Ali Patel2, Ayaz Khurram Mallick3
1Almanac Life Science India Private Limited, Jamia Nagar, New Delhi-110025, India. tariqueaiims@gmail.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|December 28, 2025
概括
调节胆固醇的蛋白质PCSK9中的功能丧失变体显示出结构变化和与其受体的结合减少. 这表明,与这些PCSK9变种相关的较低心血管疾病风险的分子基础.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 心血管疾病 (CVD) 是一个主要的全球健康问题.
- 肝蛋白PCSK9 (proprotein convertase subtilisin/kexin-type-9) 通过向LDL受体 (LDLR) 进行降解来调节低密度脂蛋白 (LDL) 水平.
- 功能丧失 (LOF) PCSK9变体与降低的LDL胆固醇和潜在的降低心血管疾病风险有关.
研究的目的:
- 研究PCSK9 LOF变异对LDLR结合的结构和功能影响.
- 了解PCSK9 LOF变种心脏保护作用背后的分子机制.
主要方法:
- 对PCSK9 LOF变体的计算分析,包括稳定性,灵活性和自由能量计算.
- 野生型和突变PCSK9与LDLR的蛋白质-蛋白质对接模拟.
- 模拟分子动力学以评估复杂的稳定性和相互作用.
主要成果:
- 与野生类型相比,PCSK9 LOF变种在蛋白质稳定性,灵活性和自由能量方面表现出显著的变化.
- 对接研究揭示了突变PCSK9和LDLR之间明显的结合相互作用和能量,尽管结合腔没有变化.
- 分子动力学模拟表明突变PCSK9-LDLR复合体的灵活性和溶剂暴露增加.
结论:
- PCSK9 LOF变种诱导了实质性的结构变化,降低了它们对LDLR的亲和力.
- 这些发现为降低LDL清除率和与PCSK9 LOF变异相关的较低心血管风险提供了分子解释.
相关概念视频
01:29Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
01:26Coronary Artery Disease II: Pathophysiology
336
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
01:30Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
01:26Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:30Atherosclerosis I: Introduction
765
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
765